McClements W L, Armstrong M E, Keys R D, Liu M A
Department of Virus and Cell Biology, Merck Research Laboratories, West Point, PA 19486, USA.
Vaccine. 1997 Jun;15(8):857-60. doi: 10.1016/s0264-410x(96)00246-0.
Plasmid expression vectors encoding herpes simplex virus type 2 (HSV-2) glycoproteins B (gB) or D (gD) were constructed and tested for their ability to immunize guinea pigs against genital HSV infection. Immunization with a plasmid expressing the aminoterminal 707 amino acids (aa) of gB induced humoral immune responses detected by ELISA and virus neutralization. When challenged by vaginal infection, immunized animals were partially protected from genital herpes, exhibiting significantly reduced primary and subsequent recurrent disease. When the gB plasmid was combined with a plasmid expressing full-length gD, immunized guinea pigs developed humoral responses to both proteins and were also significantly protected from viral challenge.
构建了编码单纯疱疹病毒2型(HSV - 2)糖蛋白B(gB)或D(gD)的质粒表达载体,并测试了它们免疫豚鼠抵抗生殖器HSV感染的能力。用表达gB氨基末端707个氨基酸(aa)的质粒进行免疫,通过ELISA和病毒中和检测到体液免疫反应。当通过阴道感染进行攻击时,免疫动物受到部分保护,免受生殖器疱疹感染,原发性和随后的复发性疾病显著减轻。当gB质粒与表达全长gD的质粒联合使用时,免疫的豚鼠对两种蛋白均产生体液反应,并且也受到显著保护,免受病毒攻击。